VYGR vs. RDIV
VYGR (Voyager Therapeutics, Inc.) is a stock, while RDIV (Invesco S&P Ultra Dividend Revenue ETF) is Mid Cap Value Equities fund tracking the S&P 900 Dividend Revenue-Weighted Index. Over the past 10 years, VYGR returned -11.43%/yr vs 10.90%/yr for RDIV. At a 0.26 correlation, their price movements are largely independent.
Performance
VYGR vs. RDIV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VYGR achieves a -5.34% return, which is significantly lower than RDIV's 12.46% return. Over the past 10 years, VYGR has underperformed RDIV with an annualized return of -11.43%, while RDIV has yielded a comparatively higher 10.90% annualized return.
VYGR
- 1D
- 0.00%
- 1M
- -2.11%
- YTD
- -5.34%
- 6M
- -11.64%
- 1Y
- 25.25%
- 3Y*
- -32.19%
- 5Y*
- -3.21%
- 10Y*
- -11.43%
RDIV
- 1D
- 0.50%
- 1M
- -1.05%
- YTD
- 12.46%
- 6M
- 11.90%
- 1Y
- 27.53%
- 3Y*
- 19.35%
- 5Y*
- 11.27%
- 10Y*
- 10.90%
VYGR vs. RDIV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VYGR Voyager Therapeutics, Inc. | -5.34% | -30.69% | -32.82% | 38.36% | 125.09% | -62.10% | -48.75% | 48.40% | -43.37% | 30.30% |
RDIV Invesco S&P Ultra Dividend Revenue ETF | 12.46% | 12.36% | 15.17% | 4.66% | 7.16% | 29.12% | -9.31% | 22.62% | -4.78% | 11.63% |
Correlation
The correlation between VYGR and RDIV is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Nov 11, 2015 | 0.26 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VYGR vs. RDIV — Risk / Return Rank
VYGR
RDIV
VYGR vs. RDIV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Voyager Therapeutics, Inc. (VYGR) and Invesco S&P Ultra Dividend Revenue ETF (RDIV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VYGR | RDIV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.68 | ||
| Sortino ratioReturn per unit of downside risk | -2.01 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.36 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | 0.67 | 5.71 | -5.04 |
| Martin ratioReturn relative to average drawdown | 1.18 | 16.39 | -15.21 |
Loading charts...
Drawdowns
VYGR vs. RDIV - Drawdown Comparison
The maximum VYGR drawdown since its inception was -92.11%, which is greater than RDIV's maximum drawdown of -49.97%. Use the drawdown chart below to compare losses from any high point for VYGR and RDIV.
Loading charts...
Drawdown Indicators
| VYGR | RDIV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.11% | -49.97% | -42.14% |
Max Drawdown (1Y)Largest decline over 1 year | -37.71% | -4.84% | -32.87% |
Max Drawdown (3Y)Largest decline over 3 years | -77.12% | -17.91% | -59.21% |
Max Drawdown (5Y)Largest decline over 5 years | -80.49% | -24.89% | -55.60% |
Max Drawdown (10Y)Largest decline over 10 years | -92.11% | -49.97% | -42.14% |
Current DrawdownCurrent decline from peak | -88.12% | -3.68% | -84.44% |
Average DrawdownAverage peak-to-trough decline | -66.94% | -5.84% | -61.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.39% | 1.68% | +19.71% |
Volatility
VYGR vs. RDIV - Volatility Comparison
Voyager Therapeutics, Inc. (VYGR) has a higher volatility of 15.00% compared to Invesco S&P Ultra Dividend Revenue ETF (RDIV) at 4.51%. This indicates that VYGR's price experiences larger fluctuations and is considered to be riskier than RDIV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VYGR | RDIV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.00% | 4.51% | +10.49% |
Volatility (6M)Calculated over the trailing 6-month period | 43.80% | 8.96% | +34.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.00% | 13.39% | +51.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.84% | 17.47% | +63.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 75.81% | 21.90% | +53.91% |
Dividends
VYGR vs. RDIV - Dividend Comparison
VYGR has not paid dividends to shareholders, while RDIV's dividend yield for the trailing twelve months is around 4.59%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RDIV Invesco S&P Ultra Dividend Revenue ETF | 4.59% | 3.94% | 4.08% | 3.93% | 3.44% | 3.31% | 4.93% | 3.84% | 4.32% | 4.26% | 2.20% | 4.49% |
VYGR Voyager Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
VYGR and RDIV have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VYGR has higher volatility (15.00%) compared to RDIV (4.51%). In terms of maximum drawdown, VYGR dropped -92.11% vs RDIV's -49.97%.
RDIV currently has the higher Sharpe Ratio (2.07 vs 0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VYGR and RDIV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer